Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: Structural and biochemical implications |
| |
Authors: | Taner Kaya Kelly S. Persons Scott C. Mohr |
| |
Affiliation: | a Boston University School of Medicine, 85 East Newton Street, Boston, MA 02118, USA b Boston University, Boston, MA 02215, USA |
| |
Abstract: | Structure-functional characterization of vitamin D receptor (VDR) requires identification of structurally distinct areas of VDR-ligand-binding domain (VDR-LBD) important for biological properties of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). We hypothesized that covalent attachment of the ligand into VDR-LBD might alter ‘surface structure’ of that area influencing biological activity of the ligand. We compared anti-proliferative activity of three affinity alkylating derivatives of 1,25(OH)2D3 containing an alkylating probe at 1,3 and 11 positions. These compounds possessed high-affinity binding for VDR; and affinity labeled VDR-LBD. But, only the analog with probe at 3-position significantly altered growth in keratinocytes, compared with 1,25(OH)2D3. Molecular models of these analogs, docked inside VDR-LBD tentatively identified Ser237 (helix-3: 1,25(OH)2D3-1-BE), Cys288 (β-hairpin region: 1,25(OH)2D3-3-BE,) and Tyr295 (helix-6: 1,25(OH)2D3-11-BE,) as amino acids that are potentially modified by these reagents. Therefore, we conclude that the β-hairpin region (modified by 1,25(OH)2D3-3-BE) is most important for growth inhibition by 1,25(OH)2D3, while helices 3 and 6 are less important for such activity. |
| |
Keywords: | 1,25(OH)2D3, 1α,25-dihydroxyvitamin D3 VDR, nuclear vitamin D receptor reVDR, recombinant vitamin D receptor VDR-LBD, vitamin D receptor-ligand-binding domain 1,25(OH)2D3-1-BE, 1α,25-dihydroxyvitamin D3-1α-(2)-bromoacetate 3H-125(OH)2D3-1-BE, 1α,25-dihydroxy[26(27)-3H]vitamin D3-1α-(2)-bromoacetate 1,25(OH)2D3-3-BE, 1α,25-dihydroxyvitamin D3-3β-(2)-bromoacetate 14C-1,25(OH)2D3-3-BE, 1α,25-dihydroxyvitamin D3-3β-[1-14C]-(2)-bromoacetate 1,25(OH)2D3-6-BE, 1α,25-dihydroxyvitamin D3-6-propoxy-(2)-bromoacetate 1,25(OH)2D3-11-BE, 1α25-dihydroxyvitamin D3-11α-hydroxy-(2)-bromoacetate 14C-1,25(OH)2D3-11-BE, 1α,25-dihydroxyvitamin D3-11α-hydroxy-[1-14C]-(2)-bromoacetate |
本文献已被 ScienceDirect 等数据库收录! |
|